Chronic viral hepatitis: the histology report. (Q37860676)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21459339%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

title

Chronic viral hepatitis: the histology report (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21459339%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

1 reference

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21459339%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

Maria Guido

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21459339%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

Alessandra Mangia

series ordinal

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21459339%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

Gruppo Italiano Patologi Apparato Digerente (GIPAD)

series ordinal

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21459339%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

Società Italiana di Anatomia Patologica e Citopatologia Diagnostica/International Academy of Pathology, Italian division (SIAPEC/IAP)

series ordinal

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21459339%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

publication date

1 March 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21459339%20AND%20SRC:MED&resulttype=core&format=json

Digestive and Liver Disease

27 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21459339%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

volume

43 Suppl 4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21459339%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

page(s)

S331-43

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21459339%20AND%20SRC:MED&resulttype=core&format=json

A classification of chronic hepatitis

27 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2811%2960589-6

7 January 2021

Chronic viral hepatitis B and C: an argument against the conventional classification of chronic hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2811%2960589-6

7 January 2021

The nomenclature of chronic active hepatitis: an obituary.

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2811%2960589-6

7 January 2021

Chronic hepatitis C: the beginning of the end of a time-honored nomenclature?

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2811%2960589-6

7 January 2021

Grading and staging the histopathological lesions of chronic hepatitis: the Knodell histology activity index and beyond

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2811%2960589-6

7 January 2021

https://api.crossref.org/works/10.1016%2FS1590-8658%2811%2960589-6

1 reference

7 January 2021

Hepatitis B virus epidemiology, disease burden, treatment, and current and emerging prevention and control measures

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2811%2960589-6

7 January 2021

Changing patterns of hepatitis B infection in Italy and NAT testing for improving the safety of blood supply

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2811%2960589-6

7 January 2021

Epidemiology of hepatitis B and C viruses: a global overview

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2811%2960589-6

7 January 2021

The changing epidemiology and natural history of hepatitis C virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2811%2960589-6

7 January 2021

The use of molecular assays in the management of viral hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2811%2960589-6

7 January 2021

Natural history of chronic hepatitis B: special emphasis on disease progression and prognostic factors

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2811%2960589-6

7 January 2021

EASL clinical practice guidelines

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2811%2960589-6

7 January 2021

New and emerging treatment of chronic hepatitis B.

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2811%2960589-6

7 January 2021

Diagnosis, management, and treatment of hepatitis C

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2811%2960589-6

7 January 2021

Hepatitis C virus genetic variability: pathogenic and clinical implications

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2811%2960589-6

7 January 2021

Practice guidelines for the treatment of hepatitis C: recommendations from an AISF/SIMIT/SIMAST Expert Opinion Meeting

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2811%2960589-6

7 January 2021

Pathologic features of chronic hepatitis. A review and update

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2811%2960589-6

7 January 2021

Ground-glass, polyglucosan-like hepatocellular inclusions: A "new" diagnostic entity

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2811%2960589-6

7 January 2021

The pathology of hepatitis C

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2811%2960589-6

7 January 2021

Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2811%2960589-6

7 January 2021

Histological grading and staging in chronic hepatitis: clinical applications and problems

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2811%2960589-6

7 January 2021

Knodell RG, Ishak KG, Black WC, Chen TS, Craig R, Kaplowitz N, Kiernan TW, Wollman J. Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis [Hepatology 1981;1:431-435].

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2811%2960589-6

7 January 2021

Classification of chronic viral hepatitis: a need for reassessment

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2811%2960589-6

7 January 2021

An algorithm for the grading of activity in chronic hepatitis C. The METAVIR Cooperative Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2811%2960589-6

7 January 2021

Histological grading and staging of chronic hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2811%2960589-6

7 January 2021

Histological classification and quantitation of the severity of chronic hepatitis: keep it simple!

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2811%2960589-6

7 January 2021

Liver biopsy assessment in chronic viral hepatitis: a personal, practical approach

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2811%2960589-6

7 January 2021

Grading and staging systems for inflammation and fibrosis in chronic liver diseases

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2811%2960589-6

7 January 2021

Liver biopsy sampling in chronic viral hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2811%2960589-6

7 January 2021

Impact of liver biopsy size on histological evaluation of chronic viral hepatitis: the smaller the sample, the milder the disease

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2811%2960589-6

7 January 2021

Sampling variability of liver fibrosis in chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2811%2960589-6

7 January 2021

Coarse vs. fine needle aspiration biopsy for the assessment of diffuse liver disease from hepatitis C virus-related chronic hepatitis.

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2811%2960589-6

7 January 2021

Ultrasound-assisted percutaneous liver biopsy: superiority of the Tru-Cut over the Menghini needle for diagnosis of cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2811%2960589-6

7 January 2021

Liver biopsy in cirrhotic patients

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2811%2960589-6

7 January 2021

Transjugular liver biopsy: how good is it for accurate histological interpretation?

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2811%2960589-6

7 January 2021

Reproducibility of liver biopsy grading and staging.

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2811%2960589-6

7 January 2021

Clinical practice and ideal liver biopsy sampling standards:Not just a matter of centimeters

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2811%2960589-6

7 January 2021

https://api.crossref.org/works/10.1016%2FS1590-8658%2811%2960589-6

1 reference

7 January 2021

Sampling error and intraobserver variation in liver biopsy in patients with chronic HCV infection

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2811%2960589-6

7 January 2021

Intra-observer and inter-observer variation in the histopathological assessment of chronic viral hepatitis.

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2811%2960589-6

7 January 2021

Interobserver study of liver histopathology using the Ishak score in patients with chronic hepatitis C virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2811%2960589-6

7 January 2021

Interobserver variation in interpretation of serial liver biopsies from patients with chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2811%2960589-6

7 January 2021

Sources of variability in histological scoring of chronic viral hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2811%2960589-6

7 January 2021

Mechanisms and significance of liver steatosis in hepatitis C virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2811%2960589-6

7 January 2021

Worsening of steatosis is an independent factor of fibrosis progression in untreated patients with chronic hepatitis C and paired liver biopsies.

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2811%2960589-6

7 January 2021

Relationship between steatosis, inflammation, and fibrosis in chronic hepatitis C: a meta-analysis of individual patient data.

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2811%2960589-6

7 January 2021

Steatosis accelerates the progression of liver damage of chronic hepatitis C patients and correlates with specific HCV genotype and visceral obesity

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2811%2960589-6

7 January 2021

Impact of obesity, steatosis and insulin resistance on progression and response to therapy of hepatitis C.

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2811%2960589-6

7 January 2021

Impact of hepatic steatosis on viral kinetics and treatment outcome during antiviral treatment of chronic HCV infection

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2811%2960589-6

7 January 2021

Prevalence of liver steatosis in patients with chronic hepatitis B: a study of associated factors and of relationship with fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2811%2960589-6

7 January 2021

Hepatic steatosis in chronic hepatitis B patients is associated with metabolic factors more than viral factors

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2811%2960589-6

7 January 2021

Correlation of paired liver biopsies in morbidly obese patients with suspected nonalcoholic fatty liver disease

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2811%2960589-6

7 January 2021

Assessment of hepatic steatosis by expert pathologists: the end of a gold standard

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2811%2960589-6

7 January 2021

Reduced serum hepcidin levels in patients with chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2811%2960589-6

7 January 2021

Liver iron excess in patients with hepatocellular carcinoma developed on viral C cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2811%2960589-6

7 January 2021

Metals, oxidative stress, and hepatic fibrogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2811%2960589-6

7 January 2021

Effects of iron overload and hepatitis C virus positivity in determining progression of liver fibrosis in thalassemia following bone marrow transplantation.

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2811%2960589-6

7 January 2021

Hepatic iron concentration as a predictor of response to interferon alfa therapy in chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2811%2960589-6

7 January 2021

Serum ferritin as a predictor of treatment outcome in patients with chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2811%2960589-6

7 January 2021

Iron reduction as an adjuvant to interferon therapy in patients with chronic hepatitis C who have previously not responded to interferon: a multicenter, prospective, randomized, controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2811%2960589-6

7 January 2021

Successful interferon therapy reverses enhanced hepatic iron accumulation and lipid peroxidation in chronic hepatitis C

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2811%2960589-6

7 January 2021

Iron reduction before and during interferon therapy of chronic hepatitis C: results of a multicenter, randomized, controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2811%2960589-6

7 January 2021

Iron stores, response to alpha-interferon therapy, and effects of iron depletion in chronic hepatitis C

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2811%2960589-6

7 January 2021

Liver pathology in genetic hemochromatosis: a review of 135 homozygous cases and their bioclinical correlations

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2811%2960589-6

7 January 2021

Liver cell dysplasia: a premalignant condition

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2811%2960589-6

7 January 2021

Large liver cell dysplasia: a controversial entity.

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2811%2960589-6

7 January 2021

Morphologic studies of the liver cell dysplasia

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2811%2960589-6

7 January 2021

Liver cell dysplasia is a major risk factor for hepatocellular carcinoma in cirrhosis: a prospective study

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2811%2960589-6

7 January 2021

Prevalence of liver cell dysplasia and association with HCC in a series of 100 cirrhotic liver explants

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2811%2960589-6

7 January 2021

Predictive value of liver cell dysplasia for development of hepatocellular carcinoma in patients with non-cirrhotic and cirrhotic chronic viral hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2811%2960589-6

7 January 2021

Predictive value of liver cell dysplasia for development of hepatocellular carcinoma in patients with chronic hepatitis B.

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2811%2960589-6

7 January 2021

Chromosomal abnormalities in liver cell dysplasia detected by comparative genomic hybridisation

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2811%2960589-6

7 January 2021

Hepatic precancerous lesions and small hepatocellular carcinoma.

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2811%2960589-6

7 January 2021

Cytoplasmic expression of hepatitis B core antigen in chronic hepatitis B virus infection: role of precore stop mutants

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2811%2960589-6

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2811%2960589-6

7 January 2021

Interaction of non-alcoholic fatty liver disease with other liver diseases.

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2811%2960589-6

7 January 2021

Chronic hepatitis C and superimposed nonalcoholic fatty liver disease

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2811%2960589-6

7 January 2021

Evidence for a role of nonalcoholic steatohepatitis in hepatitis C: a prospective study

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2811%2960589-6

7 January 2021

10.1016/S1590-8658(11)60589-6

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21459339%20AND%20SRC:MED&resulttype=core&format=json

release_4pfyusfcfrh6jood6wzynnmvpu

27 January 2020

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/4pfyusfcfrh6jood6wzynnmvpu

24 November 2022

mapped directly with Wikidata item

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21459339%20AND%20SRC:MED&resulttype=core&format=json